Cargando…
2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy
Designs, such as the Eff-Tox, OBD (optimal biological dose), STEIN (simple efficacy toxicity interval), and TEPI (toxicity efficacy probability interval) designs, have been proposed to determine the optimal dose of a new oncology drug using both efficacy and toxicity. The goal of these designs is to...
Autores principales: | Ananthakrishnan, Revathi, Green, Stephanie, Li, Daniel, LaValley, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881644/ https://www.ncbi.nlm.nih.gov/pubmed/31799471 http://dx.doi.org/10.1016/j.conctc.2019.100461 |
Ejemplares similares
-
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2018) -
Systematic comparison of the statistical operating characteristics of various Phase I oncology designs
por: Ananthakrishnan, Revathi, et al.
Publicado: (2016) -
An overview of the BOIN design and its current extensions for novel early-phase oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2022) -
Randomized clinical trials to identify optimal antibiotic treatment duration
por: Horsburgh, C Robert, et al.
Publicado: (2013) -
The ACR20 and defining a threshold for response in rheumatic diseases: too much of a good thing
por: Felson, David T, et al.
Publicado: (2014)